Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-137677

Published: 2020

Journal Articles

Health Care Reimbursement and Service Utilization Among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings

Neil Dunavin, MD, Lih-Wen Mau, PhD MPH, Christa Lea Meyer, MS, Clint Divine, Al-Ola Abdallah, MD, Susan Leppke, MPH, Anita D'Souza, MBBS, Ellen Denzen, MS, Wael Saber, MD MS, Linda J. Burns, MD, Siddhartha Ganguly, MD

Blood (2018) 132 (Supplement 1): 832.

https://doi.org/10.1182/blood-2018-99-118423

Published: 2018

Journal Articles

Healthcare Reimbursement and Service Utilization for One Year of Post-Allogeneic Hematopoietic Cell Transplantation (alloHCT) Care for Medicare Beneficiaries Ages 65 and Older with Acute Myeloid Leukemia

Lih-Wen Mau, PhD MPH, Christa Lea Meyer, MS, Linda J. Burns, MD, Wael Saber, MD MS, Patricia Steinert, PhD, David Vanness, PhD, Jaime Preussler, MS, Alicia Silver, MPP, Susan Leppke, MPH, Elizabeth Anne Murphy, EdD, Ellen Denzen, MS

Blood (2017) 130 (Supplement 1): 4695.

https://doi.org/10.1182/blood.V130.Suppl_1.4695.4695

Published: 2017

Journal Articles

National Survey Demonstrates Practice Gaps in Cytogenetic and Molecular Testing in Acute Myeloid Leukemia

Jessica K. Altman, MD, Ellen Denzen, MS, AnneMarie W. Block, PhD, Robert P. Hasserjian, MD, Heidi Klepin, MD, Bruno C Medeiros, MD, Amanda Noe, Wendy E Scales, PhD, Martin S. Tallman, MD, Kathleen Wiley, RN MSN AOCNS, Linda J. Burns, MD

Blood (2017) 130 (Supplement 1): 5602.

https://doi.org/10.1182/blood.V130.Suppl_1.5602.5602

Published: 2017

Journal Articles

What Do Transplant Physicians Think about Palliative Care? A National Survey Study

Areej El-Jawahri, MD, Thomas W. LeBlanc, MD MA, Linda J. Burns, MD, Ellen Denzen, MS, Christa Lea Meyer, MS, Lih-Wen Mau, PhD MPH, Eric J. Roeland, MD, William A. Wood, MD MPH, Effie Petersdorf, MD

Blood (2017) 130 (Supplement 1): 3388.

https://doi.org/10.1182/blood.V130.Suppl_1.3388.3388

Published: 2017

Journal Articles

Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study

Blood (2017) 130 (Supplement 1): 331.

https://doi.org/10.1182/blood.V130.Suppl_1.331.331

Published: 2017

Journal Articles

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis

Kristjan Paulson, MD, Ruta Brazauskas, PhD, Naya He, MPH, David Szwajcer, MD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Yoshiko Atsuta, MD PhD, Jignesh D Dalal, MD, Theresa Hahn, PhD, Carmem Bonfim, MD, Nandita Khera, MD, Linda J. Burns, MD, Lih-Wen Mau, PhD MPH, Navneet S. Majhail, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 842.

https://doi.org/10.1182/blood.V128.22.842.842

Published: 2016

Journal Articles

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Christopher Strouse, MD, Ying Zhang, Mei-Jie Zhang, PhD, Alyssa DiGilio, MS, Marcelo C. Pasquini, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD, Muthalagu Ramanathan, MD, Wichai Chinratanalab, MD, Alison W Loren, MD MS, Linda J. Burns, MD, Andrew Artz, MD, Kathleen F. Villa, MS, Wael Saber, MD MS

Blood (2016) 128 (22): 983.

https://doi.org/10.1182/blood.V128.22.983.983

Published: 2016

Journal Articles

Haploidentical Natural Killer Cell Infusion Induces Remission in Non-Hodgkin Lymphoma and Overcomes Resistance to Rituximab

Veronika Bachanova, MD, Dhifaf Sarhan, PhD, Todd E. DeFor, MS, Sarah Cooley, MD, Angela Panoskaltsis-Mortari, PhD, Michael R. Verneris, MD, Bruce R. Blazar, MD, Julie Curtsinger, PhD, Linda J. Burns, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD

Blood (2016) 128 (22): 3030.

https://doi.org/10.1182/blood.V128.22.3030.3030

Published: 2016

Journal Articles

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Blood (2014) 124 (21): 209.

https://doi.org/10.1182/blood.V124.21.209.209

Published: 2014

Journal Articles

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

Veronika Bachanova, MD, Arthur Frankel, Qing Cao, MS, Dixie Lewis, Michael Verneris, MD, Aleksandr Lazaryan, MD PhD MPH, Linda J. Burns, MD, Daniel Vallera, PhD

Blood (2014) 124 (21): 3098.

https://doi.org/10.1182/blood.V124.21.3098.3098

Published: 2014

Journal Articles

Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients

Hewan Belete, MDcal student, Linda J. Burns, MD, Ryan Shanley, MS, Manju Nayar, MBBS, Brian McClune, DO, Nishant Sahni, MDMS, Aleksandr Lazaryan, MD PhD, Veronika Bachanova, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD MS

Blood (2014) 124 (21): 3965.

https://doi.org/10.1182/blood.V124.21.3965.3965

Published: 2014

Journal Articles

The ASH Clinical Research Training Institute (CRTI) Positively Impacts The Success Of Early Career Hematologists In Patient-Oriented Clinical Research

Linda J Burns, MD, Charles P Clayton, James N. George, MD, Beverly S. Mitchell, Scott D. Gitlin, MD

Blood (2013) 122 (21): 1679.

https://doi.org/10.1182/blood.V122.21.1679.1679

Published: 2013

Journal Articles

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Veronika Bachanova, MD, Claudio Brunstein, MD, Linda J. Burns, MD, Tao Wang, PhD, Jeanette Carreras, MPH, Ginna G. Laport, MD, Sonali M. Smith, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Wael Saber, MD, MS

Blood (2013) 122 (21): 161.

https://doi.org/10.1182/blood.V122.21.161.161

Published: 2013

Journal Articles

Autologous and Allogeneic Donor Transplantation for Mantle Cell Lymphoma in Rituximab Era: Impact of Pre-Transplant Burden On Survival.

Erik A Magnusson, MS, Qing Cao, MS, Michael A. Linden, MD, PhD, Linda J Burns, MD, Daniel J. Weisdorf, MD, Veronika Bachanova, MD

Blood (2012) 120 (21): 3092.

https://doi.org/10.1182/blood.V120.21.3092.3092

Published: 2012

Journal Articles

Positive Positron Emission Tomography (PET) Scan in Non-Hodgkin Lymphoma Pre-Transplant Had No Impact On Relapse and Survival After Allogenenic Transplantation

Veronika Bachanova, MD, Celalettin Ustun, MD, Qing Cao, MS, Froelich Jerry, MD, Linda J Burns, MD

Blood (2012) 120 (21): 1999.

https://doi.org/10.1182/blood.V120.21.1999.1999

Published: 2012

Journal Articles

Association of Iron Overload with Survival and Complications in Allogeneic Hematopoietic Cell Transplant Recipients: Prospective Cohort Study Using R2-MRI Measured Liver Iron Content

Bryan J Trottier, Jr., MD, Todd E. Defor, MS, Linda J Burns, MD, Sarah Cooley, MD, Navneet S. Majhail, MD, MS

Blood (2012) 120 (21): 1961.

https://doi.org/10.1182/blood.V120.21.1961.1961

Published: 2012

Journal Articles

Intermittent Zolendronic Acid (ZA) for the Prevention of Osteoporosis After Allogeneic Hematopoietic Cell Transplantation (HCT)

Parameswaran Hari, MBBS, MD, MRCP, Todd E. Defor, MS, David H. Vesole, MD, PhD, Christopher Bredeson, MD, MSc, FRCPC, Linda J Burns, MD

Blood (2012) 120 (21): 1965.

https://doi.org/10.1182/blood.V120.21.1965.1965

Published: 2012

Journal Articles

Randomized Phase III Trial of 131 iodine-Tositumomab (Bexxar)/Carmustine, Etoposide, Cytarabine, Melphalan (BEAM) Vs. Rituximab/BEAM and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL): No Difference in Progression-Free (PFS) or Overall Survival (OS)

Julie M Vose, MD, Shelly L Carter, ScD, Linda J Burns, MD, Ernesto Ayala, MD, Oliver W. Press, MD, PhD, Craig H. Moskowitz, MD, Edward A. Stadtmauer, MD, Shin Mineishi, MD, Richard F. Ambinder, Timothy S. Fenske, MD, Mary M. Horowitz, MD, Marcie Tomblyn, MD, MS

Blood (2011) 118 (21): 661.

https://doi.org/10.1182/blood.V118.21.661.661

Published: 2011

Journal Articles

Autologous (auto) Versus Allogeneic (allo) Hematopoietic Cell Transplantation (HCT) for T-NHL: A CIBMTR Analysis

Sonali Smith, MD, Linda J Burns, MD, Koen van Besien, MD, Jennifer LeRademacher, PhD, Wensheng He, PhD, Ginna G. Laport, MD, Silvia Montoto, MD, David G Maloney, MD, Phd, Parameswaran Hari, MD

Blood (2010) 116 (21): 689.

https://doi.org/10.1182/blood.V116.21.689.689

Published: 2010

NARROW

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

Health Care Reimbursement and Service Utilization Among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings

Healthcare Reimbursement and Service Utilization for One Year of Post-Allogeneic Hematopoietic Cell Transplantation (alloHCT) Care for Medicare Beneficiaries Ages 65 and Older with Acute Myeloid Leukemia

National Survey Demonstrates Practice Gaps in Cytogenetic and Molecular Testing in Acute Myeloid Leukemia

What Do Transplant Physicians Think about Palliative Care? A National Survey Study

Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Haploidentical Natural Killer Cell Infusion Induces Remission in Non-Hodgkin Lymphoma and Overcomes Resistance to Rituximab

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients

The ASH Clinical Research Training Institute (CRTI) Positively Impacts The Success Of Early Career Hematologists In Patient-Oriented Clinical Research

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Autologous and Allogeneic Donor Transplantation for Mantle Cell Lymphoma in Rituximab Era: Impact of Pre-Transplant Burden On Survival.

Positive Positron Emission Tomography (PET) Scan in Non-Hodgkin Lymphoma Pre-Transplant Had No Impact On Relapse and Survival After Allogenenic Transplantation

Association of Iron Overload with Survival and Complications in Allogeneic Hematopoietic Cell Transplant Recipients: Prospective Cohort Study Using R2-MRI Measured Liver Iron Content

Intermittent Zolendronic Acid (ZA) for the Prevention of Osteoporosis After Allogeneic Hematopoietic Cell Transplantation (HCT)

Randomized Phase III Trial of 131 iodine-Tositumomab (Bexxar)/Carmustine, Etoposide, Cytarabine, Melphalan (BEAM) Vs. Rituximab/BEAM and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL): No Difference in Progression-Free (PFS) or Overall Survival (OS)

Autologous (auto) Versus Allogeneic (allo) Hematopoietic Cell Transplantation (HCT) for T-NHL: A CIBMTR Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only